You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience

Citation Tools

Article menu

Download PDFPDF

Oesophagus and Stomach
Research
Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ortiz-Fernández-Sordo J, Sami S, Mansilla-Vivar R, et al
Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience
Frontline Gastroenterology 2016;7:24-29.